Dr. Anna E. Hadid, MD

Dr. Hadid practices at AdventHealth Zephyrhills in Zephyrhills, Florida, part of AdventHealth.

Dr. Hadid's NPI, 1477554137, was assigned on August 3, 2005. Dr. Hadid graduated from American University of the Caribbean School of Medicine in 2001. Dr. Hadid holds Florida license ME134697.

Dr. Hadid's primary practice is AdventHealth Zephyrhills, at 7050 Gall Blvd, Zephyrhills, FL 33541 in Pasco County. The practice phone is (813) 615-7219.

Dr. Hadid's primary practice is AdventHealth Zephyrhills in Zephyrhills, Florida, part of AdventHealth. Dr. Hadid is also affiliated with AdventHealth Tampa. The medical group on file is AdventHealth Medical Group Cardiovascular Surgery at Tampa. Dmand AI also links Dr. Hadid to 2 more medical groups, 1 group practice or clinic and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hadid practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Hadid's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Hadid is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Hadid's licenses on file in 2 states: Florida and Ohio.

Dmand AI lists acid reflux, acute sinusitis, acute skin infection, alzheimer's disease, aneurysm, anxiety, arteritis and arthritis among the conditions Dr. Hadid treats.

CMS data shows 1,778 Medicare services from Dr. Hadid across 10 procedure codes in 2024, for 485 Medicare patients. Medicare paid $128,067 for them.

CMS counts 485 Medicare patients who saw Dr. Hadid in 2024. The largest group is 75 to 84, with 196 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hadid's median patient age at 64, with 67% women.

In 2024, Dr. Hadid wrote 4,717 Medicare Part D claims for 511 patients. 86% of them were for generic drugs. CMS names the drug for 4,060 of them, across 86 drugs with 11 or more claims each, at $353,620 in total drug cost. In 2023, CMS named 5,876 claims across 120 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Hadid for performance year 2024, reported through an alternative payment model (APM). Dr. Hadid accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 152 general payments to Dr. Hadid from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Novo Nordisk Inc paid the most, $452.

Dr. Hadid graduated from American University of the Caribbean School of Medicine in 2001. Dr. Hadid is a member of ACP.

Dr. Hadid is in network with 8 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.